Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Investment Summary

Market Valuation
Fairly Valued
Consensus
Playing (BUY)
Best For
Capital Growth

How This Company Makes Money

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Business Quality Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

MaxDividends Quality Score

Dividend Score

Sales Growth UTHR

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin UTHR

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income UTHR

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM UTHR

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio UTHR

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

United Therapeutics Corporation UTHR

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Itself UTHR

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 19.08
Forward PE 16.42
Enterprise Value Revenue 5.78
Price Sales TTM 7.24
Enterprise Value EBITDA 10.87
Price Book MRQ 3.33

Bottom Line

United Therapeutics Corporation

UTHR
Current price
550.10 USD -3.39 USD (-0.61%)
Last closed 532.78 USD
ISIN US91307C1027
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 22 851 303 424 USD
Yield for 12 month +25.01 %
1Y
3Y
5Y
10Y
15Y
UTHR
11/21/2021 - 11/28/2021

Advanced Highlights

Current Year

+3 182 700 000 USD

Last Year

+2 877 400 000 USD

Current Quarter

+783 300 000 USD

Last Quarter

+781 500 000 USD

Current Year

+2 798 300 000 USD

Last Year

+2 567 700 000 USD

Current Quarter

+683 800 000 USD

Last Quarter

+648 100 000 USD
EBITDA 1 496 199 936 USD
Operating Margin TTM 42.23 %
Price to Earnings 19.08
Return On Assets TTM 11.61 %
PEG Ratio 2.22
Return On Equity TTM 19.32 %
Wall Street Target Price 651.86 USD
Revenue TTM 3 154 500 096 USD
Book Value 149.97 USD
Revenue Per Share TTM 72.85 USD
Dividend Share –
Quarterly Revenue Growth YOY -1.90 %
Dividend Yield –
Gross Profit TTM 2 717 299 968 USD
Earnings Per Share 27.92 USD
Diluted EPS TTM 27.92 USD
Most Recent Quarter II 2026
Quarterly Earnings Growth YOY 13.40 %
Profit Margin 41.56 %
Price to Free Cash Flow TTM 21.59

Technical Indicators UTHR

For 52 Weeks

409.07 USD 609.35 USD
50 Day MA 511.97 USD
Shares Short Prior Month 2 059 685
200 Day MA 525.86 USD
Short Ratio 4.89
Shares Short 2 800 470
Short Percent 7.62 %